sb 203580 has been researched along with uric acid in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (uric acid) | Trials (uric acid) | Recent Studies (post-2010) (uric acid) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 27,980 | 1,717 | 9,982 |
| Protein | Taxonomy | sb 203580 (IC50) | uric acid (IC50) |
|---|---|---|---|
| Solute carrier family 2, facilitated glucose transporter member 9 | Homo sapiens (human) | 300 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, X; Tang, L; Wei, Y; Xu, Y | 1 |
1 other study(ies) available for sb 203580 and uric acid
| Article | Year |
|---|---|
Uric acid induces the expression of TNF‑α via the ROS‑MAPK‑NF‑κB signaling pathway in rat vascular smooth muscle cells.
Topics: Animals; Cell Survival; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Gene Expression; Imidazoles; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pyridines; Pyrrolidines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Thiocarbamates; Tumor Necrosis Factor-alpha; Uric Acid | 2017 |